This week’s top headlines include an update from the MHRA on ‘no-deal’ Brexit devices and clinical trials guidance, the rise of global 3D printing in medicine, predictions on growth of the medical device connectivity market, and how the UK plans to unlock sci-tech within the sector.
Welcome to 2019! Including reports on a new trial for breast cancer breath tests, the effects of the NHS 10-year plan on the industry, and latest updates on Brexit, here’s what’s hitting pharma headlines in the first week of a brand-new year.
People are the lifeblood of our business at Star. Whether they are candidates looking for Star support to secure roles within pharma, devices or healthcare, or Star employees working with specific clients, we must continue to provide the very best talent to drive outcomes desired.
In a rush? Top articles making headlines in the nursing and healthcare sectors this week include the high cost of undiagnosed rare diseases, medicines getting close to EU approval, and GSK announcing their joint venture with Pfizer. Have a read!
In a world where technology is king and where 2.5 billion people are predicted to own a smartphone globally by the end of 2019, it’s safe to say that everyone has some degree of online presence, even if it’s simply having an email address.
If you’re on the hunt for a new year role, this is the perfect time to regroup and make sure you’re primed to send out those applications when we emerge bleary-eyed into 2019. Here are our top tips for making the most of the break.
It’s beginning to look a lot like Christmas…. The most wonderful time of the year is nearly upon us, but here at Star we’re still working hard to find those perfect roles for perfect candidates and end the year in style! Here we have the last Top Jobs post of 2018!
Worries around a potential six-month disruption in a no-deal Brexit, NICE’s new standards for digital tech, the predicted value of global hi-tech devices, and the government assisting Indian healthcare with AI, take a look!
Who doesn’t like to be asked their opinion at work? Turns out, plenty of us! When the boss has finished explaining the newest initiative and asks for feedback, the vast majority of us will keep our heads down, or glance from face to face, wondering if anyone will dare to speak up.
No time to browse? Pharma headlines are here! Top stories in the first week of December include GSK announcing their acquisition of a US Oncology firm, UK pharma pressing ahead with deals despite Brexit uncertainty, and the UK’s first dedicated Vaccines Manufacturing Innovation Centre is announced. Take a look -